Sharma East India Hospitals & Medical Research Q1 FY27 results: net profit down 18.8% to ₹0.26 crore
Sharma East India Hospitals & Medical Research Ltd reported standalone revenue of ₹10.76 crore in Q1 FY27, up 13.6% from ₹9.47 crore a year earlier. EBITDA fell to ₹0.86 crore and net profit to ₹0.26 crore, while basic EPS declined to ₹0.79.
Key points
- Standalone revenue was ₹10.76 crore in Q1 FY27, up ₹1.29 crore or 13.6% from Q1 FY26.
- EBITDA was ₹0.86 crore, down ₹0.07 crore or 7.5% from the year-ago quarter, with an 8.0% margin.
- Net profit was ₹0.26 crore, down ₹0.06 crore or 18.8% from Q1 FY26, and basic EPS was ₹0.79.
- Against Q4 FY26, revenue rose ₹3.29 crore or 44.0%, while net profit fell ₹0.17 crore or 39.5%.
- The stock was up 3.9% on the reaction day and 2.2% by five sessions after the pre-results close.
How did Sharma East India Hospitals & Medical Research perform in Q1 FY27?
Sharma East India Hospitals & Medical Research Ltd reported standalone revenue of ₹10.76 crore in Q1 FY27, up ₹1.29 crore or 13.6% from ₹9.47 crore in Q1 FY26. EBITDA was ₹0.86 crore, down ₹0.07 crore or 7.5%, and its margin declined to 8.0% from 9.8%.
Net profit was ₹0.26 crore, compared with ₹0.32 crore in Q1 FY26, while basic EPS fell to ₹0.79 from ₹0.97. Against Q4 FY26, revenue rose ₹3.29 crore or 44.0%, but EBITDA fell ₹0.15 crore or 14.9% and net profit fell ₹0.17 crore or 39.5%.
The figures are on a standalone basis. The filing excerpts provided do not include consolidated results for the quarter.
| ₹ crore | Q1 FY27 | Q4 FY26 | Q1 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 10.76 | 7.47 | 9.47 | +13.6% | +44.0% |
| Other income | 0.04 | 0.02 | 0.04 | +0.0% | +100.0% |
| Total expenses | 10.45 | 7.06 | 9.08 | +15.1% | +48.0% |
| EBITDA | 0.86 | 1.01 | 0.93 | −7.5% | −14.9% |
| EBITDA margin | 8.0% | 13.5% | 9.8% | −1.8 pp | −5.5 pp |
| Profit before tax | 0.35 | 0.43 | 0.43 | −18.6% | −18.6% |
| Tax | 0.09 | 0 | 0.11 | −18.2% | |
| Net profit | 0.26 | 0.43 | 0.32 | −18.8% | −39.5% |
| EPS (₹) | 0.79 | 1.31 | 0.97 | −18.6% | −39.7% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in Sharma East India Hospitals & Medical Research's costs and profit?
Total expenses rose ₹1.37 crore or 15.1% from Q1 FY26 to ₹10.45 crore, outpacing the 13.6% increase in revenue. Cost of materials increased ₹0.28 crore or 15.3% to ₹2.11 crore, employee cost rose ₹0.11 crore or 8.9% to ₹1.34 crore, and finance costs increased ₹0.08 crore or 72.7% to ₹0.19 crore.
Other expenses increased ₹0.40 crore or 12.2% to ₹3.68 crore, while depreciation fell ₹0.06 crore or 14.3% to ₹0.36 crore. Other income was unchanged at ₹0.04 crore. There was no exceptional item.
Profit before tax fell ₹0.08 crore or 18.6% to ₹0.35 crore. Tax was ₹0.09 crore, down ₹0.02 crore or 18.2% from ₹0.11 crore, and net profit declined to ₹0.26 crore. The available filing excerpts do not state a reason for the year-on-year changes in the cost lines.
| ₹ crore | Q1 FY27 | Q1 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 2.11 | 1.83 | +0.28 | +15.3% |
| Employee cost | 1.34 | 1.23 | +0.11 | +8.9% |
| Finance costs | 0.19 | 0.11 | +0.08 | +72.7% |
| Depreciation | 0.36 | 0.42 | −0.06 | −14.3% |
| Other expenses | 3.68 | 3.28 | +0.40 | +12.2% |
| Total expenses | 10.45 | 9.08 | +1.37 | +15.1% |
| Other income | 0.04 | 0.04 | 0 | +0.0% |
| Tax | 0.09 | 0.11 | −0.02 | −18.2% |
Source: Company's results filing (XBRL).
How has Sharma East India Hospitals & Medical Research done over the last 8 quarters?
Revenue rose in each of the last eight quarters on a year-on-year basis. It reached ₹10.76 crore in Q1 FY27, above ₹9.61 crore in Q3 FY26 and ₹9.47 crore in Q1 FY26, while the low in the period was ₹5.98 crore in Q4 FY25.
Net profit was ₹0.26 crore in Q1 FY27, compared with ₹0.43 crore in Q4 FY26 and ₹0.18 crore in Q3 FY26. EBITDA margin was 8.0% in Q1 FY27, the same as Q3 FY26, after reaching 13.5% in Q4 FY26.
How did Sharma East India Hospitals & Medical Research shares react?
The filing appeared after market hours. The stock closed the first tradable session up 3.9% from its pre-results close; by the next day's close, it was unchanged from that close, and by five sessions it was up 2.2%.
The Healthcare Service Provider industry median fell 0.3% on the reaction day and 1.2% by five sessions. Sharma East India Hospitals & Medical Research exceeded the industry by 4.2 percentage points on the reaction day and 3.5 percentage points over five sessions. Earlier reaction-day moves included 1.8% on 14 February 2026, 3.4% on 9 May 2025 and 2.0% on 13 August 2024.
| After the filing | Stock | Healthcare Service Provider median |
|---|---|---|
| Reaction day | +3.9% | −0.3% |
| Next day | +0.0% | −0.5% |
| 5 days | +2.2% | −1.2% |
Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.
| Results filed on | Stock on the reaction day |
|---|---|
| 30 May 2026 | −1.0% |
| 14 February 2026 | +1.8% |
| 14 November 2025 | −1.2% |
| 8 September 2025 | −2.0% |
| 9 May 2025 | +3.4% |
| 13 August 2024 | +2.0% |
Source: MarketPing price-reaction measurement.
How did other Healthcare Service Provider companies do?
Nineteen Healthcare Service Provider companies were compared with Sharma East India Hospitals & Medical Research for the quarter. Their median revenue growth was 21.2%, above the company’s 13.6% growth; four peers grew slower than the company and 15 grew faster.
Of the 19 peers whose profit was compared, 16 reported higher profit. The peer comparison was recorded as of 4 November 2026.
| Sharma East India Hospitals & Medical Research revenue growth (YoY) | +13.6% |
|---|---|
| Median of 19 other Healthcare Service Provider companies | +21.2% |
| Companies with slower revenue growth than Sharma East India Hospitals & Medical Research | 4 of 19 |
| Companies with faster revenue growth than Sharma East India Hospitals & Medical Research | 15 of 19 |
| Companies whose net profit rose | 16 of 19 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was Sharma East India Hospitals & Medical Research's revenue in Q1 FY27?
Revenue from operations was ₹10.76 crore, up 13.6% from ₹9.47 crore in Q1 FY26 (standalone).
Did Sharma East India Hospitals & Medical Research make a profit in Q1 FY27?
Yes. Net profit was ₹0.26 crore, against a net profit of ₹0.32 crore in Q1 FY26.
What was Sharma East India Hospitals & Medical Research's EPS in Q1 FY27?
Basic earnings per share were ₹0.79, against ₹0.97 in Q1 FY26.
How did Sharma East India Hospitals & Medical Research shares react to the Q1 FY27 results?
On the reaction day the stock moved +3.9% from the previous close; the median Healthcare Service Provider stock moved −0.3%.
When did Sharma East India Hospitals & Medical Research announce its Q1 FY27 results?
On 8 September 2026, in a filing to the BSE.
Sources
- Board Meeting Intimation for Approval Of IND-AS Compliant Standalone Un-Audited Financial Results For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements), Regulations 2015. (BSE, 4 August 2026) · PDF
- Reg. 34 (1) Annual Report. (BSE, 8 September 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.